David Tamborero
Overview
Explore the profile of David Tamborero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
7501
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carmona J, Chavarria E, Donoghue K, von Gertten C, Oberrauch P, Pailler E, et al.
Cancer Discov
. 2024 Jun;
14(7):1147-1153.
PMID: 38870393
Cancer Core Europe brings together the expertise, resources, and interests of seven leading cancer institutes committed to leveraging collective innovation and collaboration in precision oncology. Through targeted efforts addressing key...
2.
Edsjo A, Russnes H, Lehtio J, Tamborero D, Hovig E, Stenzinger A, et al.
J Intern Med
. 2024 May;
295(6):785-803.
PMID: 38698538
In the last decades, the development of high-throughput molecular assays has revolutionised cancer diagnostics, paving the way for the concept of personalised cancer medicine. This progress has been driven by...
3.
Rheinbay E, Nielsen M, Abascal F, Wala J, Shapira O, Tiao G, et al.
Nature
. 2023 Jan;
614(7948):E40.
PMID: 36697832
No abstract available.
4.
Horak P, Griffith M, Danos A, Pitel B, Madhavan S, Liu X, et al.
Genet Med
. 2022 Sep;
24(9):1991.
PMID: 36063163
No abstract available.
5.
Tamborero D, Dienstmann R, Rachid M, Boekel J, Lopez-Fernandez A, Jonsson M, et al.
Nat Cancer
. 2022 Apr;
3(5):649.
PMID: 35449310
No abstract available.
6.
Tamborero D, Dienstmann R, Rachid M, Boekel J, Lopez-Fernandez A, Jonsson M, et al.
Nat Cancer
. 2022 Feb;
3(2):251-261.
PMID: 35221333
There is a growing need for systems that efficiently support the work of medical teams at the precision-oncology point of care. Here, we present the implementation of the Molecular Tumor...
7.
Horak P, Griffith M, Danos A, Pitel B, Madhavan S, Liu X, et al.
Genet Med
. 2022 Feb;
24(5):986-998.
PMID: 35101336
Purpose: Several professional societies have published guidelines for the clinical interpretation of somatic variants, which specifically address diagnostic, prognostic, and therapeutic implications. Although these guidelines for the clinical interpretation of...
8.
Kordes M, Tamborero D, Lagerstedt-Robinson K, Yachnin J, Rosenquist R, Lohr J, et al.
JCO Precis Oncol
. 2022 Jan;
5:974-980.
PMID: 34994625
No abstract available.
9.
Lehtio J, Arslan T, Siavelis I, Pan Y, Socciarelli F, Berkovska O, et al.
Nat Cancer
. 2021 Dec;
2(11):1224-1242.
PMID: 34870237
Despite major advancements in lung cancer treatment, long-term survival is still rare, and a deeper understanding of molecular phenotypes would allow the identification of specific cancer dependencies and immune evasion...
10.
Martin-Izquierdo M, Abaigar M, Hernandez-Sanchez J, Tamborero D, Lopez-Cadenas F, Ramos F, et al.
Haematologica
. 2020 Jul;
106(8):2215-2223.
PMID: 32675227
Myelodysplastic syndromes (MDS) are hematological disorders at high risk of progression to secondary acute myeloid leukemia (sAML). However, the mutational dynamics and clonal evolution underlying disease progression are poorly understood...